| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2186 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1623 | 2018 |
| Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses DM Skowronski, NZ Janjua, G De Serres, S Sabaiduc, A Eshaghi, ... PloS one 9 (3), e92153, 2014 | 497 | 2014 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 444 | 2022 |
| Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study H Chung, S He, S Nasreen, ME Sundaram, SA Buchan, SE Wilson, ... bmj 374, 2021 | 354 | 2021 |
| Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring–summer 2009: four observational studies from Canada DM Skowronski, G De Serres, NS Crowcroft, NZ Janjua, N Boulianne, ... PLoS medicine 7 (4), e1000258, 2010 | 353 | 2010 |
| Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A (H1N1) pdm09 serological studies from 19 countries MD Van Kerkhove, S Hirve, A Koukounari, AW Mounts, ... Influenza Other Respir Viruses, 2012 | 236 | 2012 |
| Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad NZ Janjua, MAM Nizamy Journal of Pakistan medical association 54 (3), 116, 2004 | 190 | 2004 |
| Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis B Hajarizadeh, EB Cunningham, H Valerio, M Martinello, M Law, ... Journal of hepatology 72 (4), 643-657, 2020 | 172 | 2020 |
| Determining a global mid-upper arm circumference cut-off to assess underweight in adults (men and non-pregnant women) AM Tang, M Chung, KR Dong, P Bahwere, K Bose, R Chakraborty, ... Public Health Nutrition 23 (17), 3104-3113, 2020 | 164 | 2020 |
| Poor knowledge–predictor of nonadherence to universal precautions for blood borne pathogens at first level care facilities in Pakistan NZ Janjua, M Razaq, S Chandir, S Rozi, B Mahmood BMC infectious diseases 7, 1-11, 2007 | 155 | 2007 |
| Tracking COVID-19 discourse on twitter in North America: Infodemiology study using topic modeling and aspect-based sentiment analysis H Jang, E Rempel, D Roth, G Carenini, NZ Janjua Journal of medical Internet research 23 (2), e25431, 2021 | 154 | 2021 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 144 | 2023 |
| The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization DM Skowronski, NZ Janjua, EP Sonfack Tsafack, M Ouakki, L Hoang, ... Clinical Infectious Diseases 54 (3), 318-327, 2012 | 136 | 2012 |
| Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 DM Skowronski, NZ Janjua, G De Serres, TS Hottes, JA Dickinson, ... Bmj 342, 2011 | 134 | 2011 |
| Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort C Rossi, ZA Butt, S Wong, JA Buxton, N Islam, A Yu, M Darvishian, ... Journal of hepatology 69 (5), 1007-1014, 2018 | 132 | 2018 |
| Influenza A/subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine DM Skowronski, NZ Janjua, S Sabaiduc, G De Serres, AL Winter, ... The Journal of infectious diseases 210 (1), 126-137, 2014 | 132 | 2014 |
| The population level cascade of care for hepatitis C in British Columbia, Canada: the BC Hepatitis Testers Cohort (BC-HTC) NZ Janjua, M Kuo, A Yu, M Alvarez, S Wong, D Cook, J Wong, J Grebely, ... EBioMedicine 12, 189-195, 2016 | 130 | 2016 |
| A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season DM Skowronski, NZ Janjua, G De Serres, AL Winter, JA Dickinson, ... Clinical infectious diseases 55 (3), 332-342, 2012 | 128 | 2012 |
| Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study N Islam, M Krajden, J Shoveller, P Gustafson, M Gilbert, JA Buxton, ... The Lancet Gastroenterology & Hepatology 2 (3), 200-210, 2017 | 123 | 2017 |
